Launchorasince 2014
← Stories

Inferior Vena Cava Filter Market Global Trends and Report Analysis 2023-2028

Industry Overview of Inferior Vena Cava Filter Market

The main vein responsible for carrying deoxygenated blood to the right atrium of the heart and then to the lungs is called the inferior vena cava (IVC). In cases where there is a risk of blood clots in the legs traveling to the lungs, a specialized device known as an IVC filter is implanted into the vein. The purpose of the IVC filter is to provide improved protection against thromboembolism by preventing these blood clots from reaching the lungs. IVC filters work by trapping large clumps of blood clots and preventing their further progression into the lungs and heart, thus reducing the risks of pulmonary embolism. Typically, these filters have a cone-shaped design with six stainless steel limbs that diverge from the apex. They can be inserted into the vein either permanently or temporarily, depending on the specific medical situation.

IVC filters are primarily made from phynox, which is an MRI-compatible nonferromagnetic alloy consisting of chromium, cobalt, and nickel. This material ensures compatibility with magnetic resonance imaging (MRI) procedures and provides durability for the device. IVC filters offer an effective alternative to anticoagulant medications in preventing mortality caused by pulmonary embolism. Due to their efficacy and importance in medical interventions, IVC filters are widely utilized in hospitals and ambulatory surgical centers to enhance patient safety and reduce the risks associated with blood clots.

How Big Is the Inferior Vena Cava Filter Market?

The global inferior vena cava (IVC) filter market size reached US$ 662 Million in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 1,086 Million by 2028 exhibiting a CAGR of 8.3% during 2023-2028.

Inferior Vena Cava (IVC) Filter Market Trends and Drivers:

The global market for inferior vena cava (IVC) filters is being primarily driven by the increasing demand from patients experiencing acute venous thromboembolic events and those who have failed anticoagulation therapy. This demand is attributed to the growing prevalence of cardiovascular disorders worldwide. Additionally, the market is benefiting from the rising adoption of minimally invasive (MI) surgeries and continuous advancements in medical imaging procedures, which enhance the effectiveness of IVC filters. The establishment of more digital catheterization laboratories is also contributing to the market's growth. These advanced facilities enable improved diagnosis and treatment of cardiovascular conditions, including the use of IVC filters. Furthermore, government bodies implementing policies to raise awareness about cardiovascular disorders (CVDs) are playing a significant role in driving market expansion.

Moreover, the expanding geriatric population, which is more prone to developing various chronic ailments, is expected to further boost the demand for IVC filters in the coming years. This demographic group requires effective solutions to manage and prevent venous thromboembolism, leading to increased adoption of IVC filters. Overall, the combination of factors such as increasing cardiovascular disorders, advancements in medical procedures, government initiatives, and the aging population is expected to propel the inferior vena cava (IVC) filter market forward.

Global Inferior Vena Cava (IVC) Filter Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: ALN Implants Chirurgicaux, Argon Medical Devices Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Braile Biomédica, Cook Group Incorporated, etc.

The report segmented the market based on region, product, material, application and end user.

Product Insights

Retrievable IVC Filter

Permanent IVC Filter

Material Insights

Non-Ferromagnetic Materials

Ferromagnetic Materials

Application Insights

Treatment Venous Thromboembolism (VTE)

Prevent Pulmonary Embolism (PE)

Others

End User Insights

Hospitals

Ambulatory Surgical Centers (ASCs)

Others

Regional Insights

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The key regions covered in the market report are Asia Pacific, Europe, North America, Latin America, Middle East and Africa.

If you want latest primary and secondary data (2022-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

Market Performance (2016-2021)

Market Outlook (2023- 2028)

Porter’s Five Forces Analysis

Market Drivers and Success Factors

SWOT Analysis

Value Chain

Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800